App-based contingency management to reduce heavy drinking days among smokers receiving varenicline: Feasibility, acceptability, and efficacy indicators from a phase I analog trial.
Experimental and Clinical Psychopharmacology · 2026
DOI: 10.1037/pha0000790 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Experimental and Clinical Psychopharmacology, 2026. Verfasst von André Q C Miguel und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community and Behavioral Health, Elson S. Floyd College of Medicine, Washington State University. Hauptthemen laut MEDLINE: Varenicline, Smoking Cessation, Mobile Applications, Smoking Cessation Agents. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Washington State University Alcohol and Drug Abuse Research Program, NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Community and Behavioral Health, Elson S. Floyd College of Medicine, Washington State University.
- Department of Community and Behavioral Health, Analytics and PsychoPharmacology Laboratory, Washington State University.
ORCID-Profile: André Q C Miguel, Nicole Akana, Rachel Ryan, Alex Schmidt, Sean Hovland, Brian Stark, Sierra Colletto, Abigail Bowen, Nicole Rodin, Crystal L Smith, Sterling M McPherson
Förderung
- NCI NIH HHS
- Washington State University Alcohol and Drug Abuse Research Program
- NIH HHS
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Miguel, A. Q. C., Akana, N., Ryan, R., Schmidt, A., Hovland, S., Stark, B., Colletto, S., Bowen, A., Rodin, N., Smith, C. L., & McPherson, S. M. (2026). App-based contingency management to reduce heavy drinking days among smokers receiving varenicline: Feasibility, acceptability, and efficacy indicators from a phase I analog trial. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/pha0000790
Vancouver
Miguel AQC, Akana N, Ryan R, Schmidt A, Hovland S, Stark B, et al. App-based contingency management to reduce heavy drinking days among smokers receiving varenicline: Feasibility, acceptability, and efficacy indicators from a phase I analog trial. Experimental and Clinical Psychopharmacology. 2026. doi:10.1037/pha0000790
BibTeX
@article{Miguel2026,
author = {Miguel, André Q C and Akana, Nicole and Ryan, Rachel and Schmidt, Alex and Hovland, Sean and Stark, Brian and Colletto, Sierra and Bowen, Abigail and Rodin, Nicole and Smith, Crystal L and McPherson, Sterling M},
title = {App-based contingency management to reduce heavy drinking days among smokers receiving varenicline: Feasibility, acceptability, and efficacy indicators from a phase I analog trial},
journal = {Experimental and Clinical Psychopharmacology},
year = {2026},
doi = {10.1037/pha0000790}
}
EUVIMED